Evaluation of Performance and Safety of Carbopol 980 NF 0.2%- Based Medical Device in the Management of Patients With Glaucomar or Ocular Hypertension and Concomitant Dry Eye Syndrome on Multiple Long-term Topical Hypotensive Therapy

Stopped The investigation was prematurely interrupted with 65 patients enrolled due to difficulties in recruiting patients. However the results observed in the interim analysis demonstrate the performance of the investigational device.

Conditions

• Dry Eye Syndrome
• Glaucoma and Concomitant Dry Eye Syndrome
• Ocular Hypertension and Concomitant Dry Eye Syndrome
• Multiple Long-term Topical Hypotensive Therapy

Interventions

• DEVICE: Iridium A Gel

Sponsor

Fidia Farmaceutici s.p.a.